SCHEDULE 7 Fees

PART 2 Fees relating to marketing authorisations

Application for a marketing authorisation for an immunological product

9.  The fee for a national application for a marketing authorisation relating to an immunological product, a decentralised application where the United Kingdom is the concerned member State or the mutual recognition of a product authorised in another member State is in accordance with the following table.

Fees for specified immunological applications

Menu	National application for a marketing authorisation(£)	Decentralised application where the UK is a concerned member State or recognition of a product authorised in another member State (£)
1. Immunological product other than in paragraph 2: Base fee:	11,775	5,785
The following fees are in addition to the base fee.
Additional fee for each active ingredient not previously included in a veterinary medicinal product authorised in the United Kingdom, and for each new combination of active ingredients:	7,405	2,490
Additional fee for each adjuvant or preservative not previously included in a veterinary medicinal product authorised in the United Kingdom and for each new combination of adjuvants or preservatives:	1,345	675
More than one antigenic component – fee for each additional component:	1,350	405
More than one species – fee for each additional species	5,380	1,615
More than one route of administration – fee for each additional route of administration	5,380	1,615
Simultaneous application - fee for each additional product in the application	2,895	1,685
2. Immunological product that is identical to a product already authorised in the United Kingdom but with a lesser number of antigens and that only contains antigens contained in that product	10,430	5,380